52 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Thursday’s Close
PACB Pacific Biosciences of California, Inc. $5.14 $678.18M N/A
Article Searches
3 Top Healthcare Stocks to Buy Right Now https://www.fool.com/investing/2019/05/20/3-top-healthcare-stocks-to-buy-right-now.aspx?source=iedfolrf0000001 May 20, 2019 - These stocks are bargains.
Pump the Brakes on the Illumina and Pacific Biosciences Deal https://www.fool.com/investing/2019/04/20/pump-the-brakes-on-the-illumina-and-pacific-biosci.aspx?source=iedfolrf0000001 Apr 20, 2019 - The United Kingdom's Competition and Markets Authority has opened an investigation into the acquisition. What happens now?
Top Gene-Sequencing Stocks for 2019 https://www.fool.com/investing/2019/04/19/top-gene-sequencing-stocks-for-2019.aspx?source=iedfolrf0000001 Apr 19, 2019 - These next-generation companies are working on game-changing ways to obtain and profit from genetic insight.
Pacific Biosciences of California (PACB) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release http://www.zacks.com/stock/news/351258/pacific-biosciences-of-california-pacb-may-report-negative-earnings-know-the-trend-ahead-of-next-weeks-release?cid=CS-ZC-FT-351258 Jan 31, 2019 - Pacific Biosciences (PACB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
LMNX or PACB: Which is a Better MedTech Investment Pick? http://www.zacks.com/stock/news/345680/lmnx-or-pacb-which-is-a-better-medtech-investment-pick?cid=CS-ZC-FT-345680 Jan 04, 2019 - Luminex (LMNX) scores higher than Pacific Biosciences (PACB) considering growth projections and fundamentals.
Here's Why You Should Hold Pacific Biosciences (PACB) Now http://www.zacks.com/stock/news/341454/heres-why-you-should-hold-pacific-biosciences-pacb-now?cid=CS-ZC-FT-341454 Dec 06, 2018 - Pacific Biosciences (PACB) is likely to gain from strong prospects in the Sequel System platform. However, the company faces cutthroat competition in the DNA sequencing market.
Here's Why You Should Invest in Illumina (ILMN) Stock Now http://www.zacks.com/stock/news/337968/heres-why-you-should-invest-in-illumina-ilmn-stock-now?cid=CS-ZC-FT-337968 Nov 16, 2018 - llumina (ILMN) set to take over peer in a $1.2-billion deal, which will strengthen its position in the genomics market.
Pacific Biosciences' Sequel Sees Solid Q2, Competition Rife http://www.zacks.com/stock/news/317392/pacific-biosciences-sequel-sees-solid-q2-competition-rife?cid=CS-ZC-FT-317392 Aug 10, 2018 - Pacific Biosciences (PACB) gains from solid presence in Asia; competition likely to mar results.
Here's Why Pacific Biosciences of California, Inc. Rose 40.3% in June https://www.fool.com/investing/2018/07/09/heres-why-pacific-biosciences-of-california-inc-ro.aspx?source=iedfolrf0000001 Jul 09, 2018 - The DNA sequencing leader announced upgrades to some of its core offerings.
Why Is Pacific Biosciences (PACB) Down 6.7% Since its Last Earnings Report? http://www.zacks.com/stock/news/306116/why-is-pacific-biosciences-pacb-down-67-since-its-last-earnings-report?cid=CS-ZC-FT-306116 Jun 01, 2018 - Pacific Biosciences (PACB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Pages: 123456

Page 1>